Neurological Disorders and Covid-19 At the University Hospital of Lome
Abstract
Vinyo Kodzo Kumako, Léhleng Agba, Kossivi Apetse, Damelan Kombate, Komi Assogba, Mofou Belo and Ayelola Balogou
The current global epidemiological context is marked by the Covid-19 pandemic (Coronavirus Disease 2019), an infection due to the severe acute respiratory syndrome coronavirus 2 (SARSCov 2) that appeared in the People's Republic of China in December 2019 [1, 2]. This emerging disease, little known around the world, has been declared a Public Health Emergency of International Concern by the World Health Organization (WHO) [3]. Less well-known neurological manifestations than pulmonary ones have been reported in COVID-19-positive patients ranging from mild disorders such as smell disorders to severe conditions such as stroke [4- 6]. In sub-Saharan Africa, data on the association between COVID-19 and neurological conditions are non-existent. Togo is located in an intertropical zone of West Africa, between the meridians 0°20 and 1°50 East and the parallels 6° and 11°10 North. Its geographical location gives it warm climates with temperatures that vary between 19.1°C and 33°C. The epidemic affected Togo mainly Lomé, the capital in March 2020 [7] and three epidemic peaks occurred respectively in March-April 2021, August-September 2021, and January 2022 [8]. We conducted a hospital study whose objective is to describe the possible peculiarities of neurological conditions with recent COVID-19.